FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
675 letters match. Newest first.
-
BiologicsSperm Bank, Inc. dba Fertility Center of California
FDA warned Sperm Bank, Inc. dba Fertility Center of California over donor semen released without required infectious-disease testing and screening.
High risk -
DrugsMarshalls Traditional Healthcare CC
Marshalls Traditional Healthcare, an OTC drug maker in South Africa, lacked finished-product release testing and process validation.
High risk -
DrugsAmWiner & Raphe Holdings, LLC dba rapheGenerics Corp
FDA cited rapheGenerics for manufacturing-quality failures and unapproved minoxidil hair regrowth drugs.
High risk -
DevicesRobbins Instruments, LLC
Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.
High risk -
DrugsChengdu Innovation Pharmaceutical Co., Ltd.
FDA warned Chengdu Innovation Pharmaceutical over CGMP (manufacturing quality rules) failures in API (drug ingredient) manufacturing, including no identity testing of incoming materials.
High risk -
DrugsWuhu Nuowei Chemistry Co., Ltd.
FDA cited Wuhu Nuowei Chemistry for API CGMP deviations in impurity testing, stability data, and cleaning, and placed products on import alert.
High risk -
DrugsISOThrive, Inc.
ISOThrive ran two human studies of a supplement used as a drug without submitting a required IND.
High risk -
DrugsStrukmyer LLC dba Strukmyer Medical
Strukmyer Medical was cited for current good manufacturing practice violations after FDA found repeated microbial contamination in water used to make OTC drugs.
High risk -
DrugsCenter for Instrumental Analysis of China Pharmaceutical University
Center for Instrumental Analysis of China Pharmaceutical University cited for incomplete API testing records and no quality unit.
High risk -
DrugsSanofi
FDA warned Sanofi subsidiary Genzyme over manufacturing quality failures at its Framingham, MA API plant.
High risk -
FoodCOFISA - Conservas de Peixe da Figueira, S.A.
FDA found COFISA's canned sardine and tuna food-safety plans inadequate, with missing hazards and weak histamine (spoilage toxin) controls.
High risk -
FoodDuong Ha Processing Trading Seafood Company Limited
FDA warns Vietnam seafood processor Duong Ha over HACCP failures for frozen scombrotoxin-forming fish.
High risk -
FoodSalt City Baking Company, LLC
FDA says Salt City Baking's ready-to-eat bread was made under insanitary conditions, with insects, mold and missing food-safety controls.
High risk -
DevicesHologic, Inc.
FDA warns Hologic over design-control and reporting failures for implantable BioZorb markers, including missed medical device reports and a correction report.
High risk -
DevicesPhillips Precision, Inc.
FDA says Phillips Precision, a contract maker of orthopedic implants and instruments, violated device quality rules for cleaning and process controls.
High risk -
DevicesRandox Laboratories Limited
FDA warned Randox Laboratories over inadequate risk analysis and corrective actions for carryover errors in RX series analyzers.
High risk -
DrugsIndoco Remedies Limited
FDA warned Indoco Remedies over manufacturing quality failures at its Goa plant, including unreliable microbial testing and aseptic processing deficiencies.
High risk -
DrugsBhargava Phytolab Private Limited
FDA warns Bhargava Phytolab over drug and API current good manufacturing practice (CGMP) violations, including inadequate testing and sterility controls.
High risk -
DrugsViatris, Inc.
FDA warns Viatris that its Indore, India, drug plant had unreliable quality data and weak investigations.
High risk -
DrugsSombra Cosmetics, Inc.
FDA warned Sombra Cosmetics of OTC drug CGMP violations, including inadequate water controls and component testing.
High risk -
DevicesAnne’s Daye Ltd dba Tampon Innovations
FDA says Anne’s Daye marketed CBD-coated tampons and vaginal screening kits without required device clearance or approval.
High risk -
FoodLoyd Sanabria Hernandez dba Avicola Santa Fe
FDA warns Puerto Rico shell egg farm Avicola Santa Fe over Salmonella prevention, testing, and registration failures.
High risk -
DevicesRontis Hellas S.A.
Rontis Hellas made Cronus HP PTA balloon catheters with an unproven EtO sterilization process and inadequate US adverse-event reporting procedures.
High risk -
DrugsMicro Orgo Chem
Micro Orgo Chem in India failed CGMP for API drugs, including cleaning, process validation, stability and records.
High risk -
AnimalMid America Pet Food LLC
FDA warned Mid America Pet Food after Salmonella-linked recalls and found persistent contamination and animal-food safety-rule violations at its Texas plant.
High risk -
DrugsDr. Brite, LLC
FDA cited Dr. Brite for manufacturing quality failures and selling unapproved, misbranded oral care and hand sanitizer drugs.
High risk -
DrugsGuangzhou Four E’s Scientific Co., Ltd.
FDA warns Guangzhou Four E’s over CGMP failures for OTC drugs, including a sterile-labeled product with inadequate sterility assurance.
High risk -
FoodPurcell International
Purcell International imported cinnamon apple sauce linked to lead contamination without adequate foreign supplier verification.
High risk -
FoodCaribbean Produce Exchange, LLC
Caribbean Produce Exchange lacked required foreign supplier verification records for imported WanaBana apple cinnamon puree linked to lead recall.
High risk -
FoodKnickerbocker 365 Inc.
FDA says Knickerbocker 365's Michigan ready-to-eat bread plant lacked Salmonella, supplier and allergen controls.
High risk -
DrugsZhejiang Uniquality Nursing Products Technology Co., Ltd. dba ZheJiang YouQuan Care Products Technology Co., Ltd.
FDA warns Zhejiang Uniquality over inadequate OTC drug component testing and quality oversight; import alert issued.
High risk -
FoodCalavo Growers, Inc.
Calavo Growers' papayas are adulterated because contracted growers lacked accessible toilet facilities.
High risk -
FoodMena Food Group, LLC
FDA says Mena Food Group made ready-to-eat bakery products under insanitary conditions and without allergen or CGMP controls.
High risk -
DrugsEurosirel S.P.A
FDA warns Eurosirel over CGMP failures in topical drugs and pain patches, including missing glycerin identity testing.
High risk -
DrugsHangzhou Huiji Biotechnology Co., Ltd.
FDA warned Hangzhou Huiji Biotechnology over CGMP failures in OTC hand sanitizers, including missing glycerin and ethanol safety tests.
High risk -
FoodStew Leonard’s Holdings LLC
Stew Leonard's Danbury, CT bakery cookies were misbranded: labels omitted peanut and egg allergens tied to a consumer death.
High risk -
FoodMaruhachi Muramatsu Inc., Danchi Factory
FDA warns Maruhachi Muramatsu's Japan seafood plant over inadequate food safety controls for refrigerated reduced oxygen packaged skipjack tuna soup base.
High risk -
DevicesAdept Medical Ltd.
Adept Medical Ltd. warning letter cites quality system and premarket violations for NeoZoline ventilation tubes, including unvalidated sterilization.
High risk -
FoodKyokuyo Global Seafoods Co. LTD.
FDA warned Thai seafood processor Kyokuyo Global Seafoods that its HACCP plans for frozen mackerel and shrimp are inadequate, making the products adulterated.
High risk -
FoodProcesadora Vikingo C.A.
FDA says Procesadora Vikingo C.A. shipped refrigerated cooked ready-to-eat crabmeat to the U.S. after seafood HACCP violations.
High risk -
DrugsColgate-Palmolive/Tom's of Maine, Inc.
FDA cited Tom's of Maine for CGMP failures after finding objectionable microbes in water and toothpaste and inadequate complaint handling.
High risk -
DrugsMultaler et Cie SAS
FDA cites Multaler et Cie for manufacturing failures and unapproved sunscreen after April 2024 inspection.
High risk -
DevicesOwens & Minor, Inc. dba American Contract Systems, Inc.
FDA warned Owens & Minor unit American Contract Systems over device quality-system violations for sterile kits, including failed sterilization bags and incomplete design verification.
High risk -
FoodRongcheng Jiayuan Food Co., Ltd
FDA says Rongcheng Jiayuan's canned tuna is adulterated due to seafood HACCP and low-acid canned food violations.
High risk -
DevicesRolence Ent. Inc.
FDA warns Rolence Ent. Inc. over quality system and MDR failures for its XR-01 Portable X-ray System.
High risk -
FoodTop Health Manufacturing, LLC
Top Health Manufacturing's dietary supplements violated manufacturing and labeling rules, FDA says.
Medium -
DrugsOmni Lens Pvt. Ltd.
FDA warns Omni Lens about CGMP failures and misbranding of ophthalmic OTC drugs made by unregistered contract manufacturers.
High risk -
BiologicsPinnacle Transplant Technologies, LLC
FDA warns Pinnacle Transplant Technologies over unapproved injectable amniotic products and sterility CGMP failures.
High risk -
BiologicsHemarus LLC
Hemarus LLC failed blood-product manufacturing rules, including unapproved donor reinstatement and records signed when physician absent.
High risk -
DrugsOutin Futures Corp.
FDA warned Outin Futures, a Korean drug manufacturer, of CGMP violations and sunscreen misbranding after a March 2024 inspection.
High risk